25.05
Gitlab Inc stock is traded at $25.05, with a volume of 23.33M.
It is down -6.18% in the last 24 hours and down -23.02% over the past month.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
See More
Previous Close:
$26.70
Open:
$23.6
24h Volume:
23.33M
Relative Volume:
4.16
Market Cap:
$4.22B
Revenue:
$711.60M
Net Income/Loss:
$-48.60M
P/E Ratio:
-78.28
EPS:
-0.32
Net Cash Flow:
$-105.28M
1W Performance:
-3.54%
1M Performance:
-23.02%
6M Performance:
-42.36%
1Y Performance:
-60.11%
Gitlab Inc Stock (GTLB) Company Profile
Name
Gitlab Inc
Sector
Industry
Phone
650-474-5175
Address
268 BUSH STREET, SAN FRANCISCO
Compare GTLB vs MSFT, ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GTLB
Gitlab Inc
|
25.05 | 4.50B | 711.60M | -48.60M | -105.28M | -0.32 |
|
MSFT
Microsoft Corporation
|
405.20 | 3.00T | 305.45B | 119.26B | 77.41B | 15.98 |
|
ORCL
Oracle Corp
|
152.37 | 428.27B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
PLTR
Palantir Technologies Inc
|
153.19 | 352.10B | 4.48B | 1.63B | 2.10B | 0.6328 |
|
CRWD
Crowdstrike Holdings Inc
|
407.68 | 98.68B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
430.98 | 81.28B | 8.00B | 1.10B | 2.28B | 6.4708 |
Gitlab Inc Stock (GTLB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-12-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-07-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-17-25 | Initiated | BTIG Research | Buy |
| Dec-16-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Dec-03-25 | Downgrade | Macquarie | Outperform → Neutral |
| Nov-19-25 | Downgrade | Truist | Buy → Hold |
| Oct-07-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-01-25 | Initiated | Wells Fargo | Equal Weight |
| Sep-11-25 | Initiated | Guggenheim | Buy |
| Aug-22-25 | Resumed | DA Davidson | Neutral |
| Jul-16-25 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jul-15-25 | Initiated | Rosenblatt | Buy |
| Jun-11-25 | Downgrade | Goldman | Buy → Neutral |
| Dec-12-24 | Initiated | Macquarie | Outperform |
| Oct-21-24 | Upgrade | Needham | Hold → Buy |
| Oct-09-24 | Initiated | Morgan Stanley | Overweight |
| Aug-27-24 | Reiterated | BofA Securities | Buy |
| Aug-27-24 | Initiated | Robert W. Baird | Outperform |
| Apr-12-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-09-24 | Initiated | Wells Fargo | Overweight |
| Mar-22-24 | Initiated | CapitalOne | Overweight |
| Mar-19-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-06-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-08-24 | Upgrade | Mizuho | Neutral → Buy |
| Nov-29-23 | Initiated | Raymond James | Mkt Perform |
| Nov-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-17-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-13-23 | Initiated | BTIG Research | Buy |
| Sep-12-23 | Initiated | Bernstein | Outperform |
| Sep-12-23 | Initiated | Canaccord Genuity | Buy |
| Jun-20-23 | Initiated | Wolfe Research | Peer Perform |
| May-10-23 | Initiated | DA Davidson | Neutral |
| Mar-30-23 | Initiated | SMBC Nikko | Neutral |
| Mar-29-23 | Initiated | Mizuho | Neutral |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Jan-23-23 | Initiated | FBN Securities | Outperform |
| Dec-15-22 | Initiated | Barclays | Overweight |
| Sep-22-22 | Initiated | MoffettNathanson | Buy |
| Sep-01-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-07-22 | Initiated | Needham | Buy |
| Jun-27-22 | Upgrade | Goldman | Neutral → Buy |
| Jun-09-22 | Initiated | Scotiabank | Sector Outperform |
| Feb-04-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-27-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-08-21 | Initiated | BofA Securities | Buy |
| Nov-08-21 | Initiated | Cowen | Outperform |
| Nov-08-21 | Initiated | Goldman | Neutral |
| Nov-08-21 | Initiated | JP Morgan | Neutral |
| Nov-08-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-08-21 | Initiated | Piper Sandler | Neutral |
| Nov-08-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-08-21 | Initiated | Truist | Buy |
| Nov-08-21 | Initiated | UBS | Buy |
View All
Gitlab Inc Stock (GTLB) Latest News
Amova Asset Management Americas Inc. Sells 278,130 Shares of GitLab Inc. $GTLB - MarketBeat
ARK Investment Management LLC Increases Holdings in GitLab Inc. $GTLB - MarketBeat
GitLab Announces Strong Q4 Results and Share Buyback - The Globe and Mail
GitLab Stock Sinks 6% Following Disappointing 2027 Revenue And Earnings Forecasts - TIKR.com
Bernstein Maintains Outperform; Cantor Holds Neutral on GitLab (GTLB) Mar 2026 - Meyka
GitLab’s AI Push And US$400m Buyback Reframe Growth And Risk - simplywall.st
BofA cuts GitLab stock price target on transition year outlook By Investing.com - Investing.com UK
GitLab aims for greater investor transparency under new CFO - CFO Dive
GitLab Sell-Off Overdone: AI and Cash Flow Signal a Rebound - MarketBeat
These Stocks Are Today’s Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More - Barron's
Wall Street Just Sent a Clear Signal on GTLB — Nine Analysts Cut Price Targets After FY27 Guidance Disappoints - AOL.com
GITLAB INC. (GTLB) Stock, Price, News, Quotes, Forecast and Insights - MSN
Why GitLab Stock Plunged 13.5% This Morning - AOL.com
OpenAI’s Platform Expansion Spurs Concern for GitLab Shares - timothysykes.com
Moderna reaches vaccine settlement, GitLab's guidance disappoints - Yahoo Finance
GitLab Shares Tumble 7.13% as Soft Sales Forecast and OpenAI 'GitHub Clone' Rumors Spook Investors - FinancialContent
Wells Fargo cuts GitLab stock price target on stabilization outlook By Investing.com - Investing.com UK
Gitlab shares fall on weaker fiscal 2027 revenue guidance By Investing.com - Investing.com UK
Gitlab Posts Q4 Revenue Beat: Analysts Cut Price Target On FY27 Being A 'Transition Year'GitLab (NASDAQ:GTLB) - Benzinga
These Stocks Are Today’s Movers: Moderna, Coinbase, Strategy, CoreWeave, GitLab, Seagate, Sandisk, and More - Barron's
Wells Fargo cuts GitLab stock price target on stabilization outlook - Investing.com Nigeria
GitLab shares dive as death-of-human-coding theme strengthens - Sherwood News
GitLab shares fall on weak guidance despite Q4 beat - Yahoo Finance
UBS Adjusts Price Target on Gitlab to $44 From $51, Maintains Buy Rating - marketscreener.com
GitLab Buyback And AI Duo Launch Raise Questions On Valuation Disconnect - Yahoo Finance
GitLab (NASDAQ:GTLB) Price Target Lowered to $26.00 at Wells Fargo & Company - MarketBeat
GitLab (NASDAQ:GTLB) Sets New 52-Week Low After Analyst Downgrade - MarketBeat
GitLab Q4 2025 Earnings: Revenue Surpasses Forecasts, Future Guidance CautiousNews and Statistics - IndexBox
GitLab Shares Down Despite Q4 Earnings Beat, Revenues Up Y/Y - TradingView
Gitlab shares fall on weaker fiscal 2027 revenue guidance - Investing.com
GitLab drops as full-year guidance falls short of market expectations - Seeking Alpha
Barclays Issues Pessimistic Forecast for GitLab (NASDAQ:GTLB) Stock Price - MarketBeat
GitLab Stock Tumbles Again. Why the Software Pain Isn’t Over. - Barron's
TD Cowen reiterates Hold on GitLab stock, keeps $29 target By Investing.com - Investing.com UK
Moderna, Coinbase, Strategy, CoreWeave, CrowdStrike, GitLab, Albemarle, and More Movers - Barron's
Stocks to Watch Wednesday: Coinbase, CrowdStrike, Gitlab, Moderna -- WSJ - 富途牛牛
TD Cowen reiterates Hold on GitLab stock, keeps $29 target - Investing.com
GitLab (NASDAQ:GTLB) Price Target Cut to $33.00 by Analysts at Royal Bank Of Canada - MarketBeat
Gitlab stock hits 52-week low at 23.41 USD By Investing.com - Investing.com Australia
Gitlab stock hits 52-week low at 23.41 USD - Investing.com
GitLab (NASDAQ:GTLB) Price Target Lowered to $50.00 at Guggenheim - MarketBeat
GitLab (NASDAQ:GTLB) Price Target Lowered to $40.00 at Canaccord Genuity Group - MarketBeat
Stock Movers: Gitlab, Abercrombie & Fitch, Ross - Bloomberg.com
Bank of America Lowers GitLab (NASDAQ:GTLB) Price Target to $58.00 - MarketBeat
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Dow, First Solar, GM, GitLab, Roblox, Ross Stores, Target, Tesla, Toll Brothers, and More - 24/7 Wall St.
CrowdStrike Holds Steady on Wednesday While GitLab Plunges 9% After Earnings - 24/7 Wall St.
GitLab (NASDAQ:GTLB) Price Target Lowered to $32.00 at Needham & Company LLC - MarketBeat
Sanford C. Bernstein Cuts GitLab (NASDAQ:GTLB) Price Target to $60.00 - MarketBeat
Canaccord cuts GitLab stock price target on growth pressure By Investing.com - Investing.com Australia
Canaccord cuts GitLab stock price target on growth pressure - Investing.com
RBC Cuts Price Target on Gitlab to $33 From $40, Keeps Outperform Rating - marketscreener.com
Gitlab Inc Stock (GTLB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):